nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—ABCC5—Rifampicin—leprosy	0.553	0.614	CbGbCtD
Alprostadil—SLCO2B1—Rifampicin—leprosy	0.348	0.386	CbGbCtD
Alprostadil—Application site pruritus—Dapsone—leprosy	0.00905	0.114	CcSEcCtD
Alprostadil—Application site pain—Dapsone—leprosy	0.00503	0.0632	CcSEcCtD
Alprostadil—Peritonitis—Thalidomide—leprosy	0.00448	0.0563	CcSEcCtD
Alprostadil—Hypochromic anaemia—Thalidomide—leprosy	0.00292	0.0367	CcSEcCtD
Alprostadil—PTGIR—blood vessel—leprosy	0.00269	0.138	CbGeAlD
Alprostadil—Peripheral vascular disorder—Thalidomide—leprosy	0.00231	0.029	CcSEcCtD
Alprostadil—Serum creatinine increased—Thalidomide—leprosy	0.00184	0.0231	CcSEcCtD
Alprostadil—Burning sensation—Thalidomide—leprosy	0.00163	0.0205	CcSEcCtD
Alprostadil—PTGER2—tendon—leprosy	0.00162	0.0829	CbGeAlD
Alprostadil—Influenza—Dapsone—leprosy	0.00139	0.0174	CcSEcCtD
Alprostadil—Numbness—Thalidomide—leprosy	0.00137	0.0172	CcSEcCtD
Alprostadil—PTGER2—testis—leprosy	0.00134	0.0686	CbGeAlD
Alprostadil—Apnoea—Thalidomide—leprosy	0.00133	0.0168	CcSEcCtD
Alprostadil—Sensory loss—Thalidomide—leprosy	0.00131	0.0164	CcSEcCtD
Alprostadil—Vasodilation—Thalidomide—leprosy	0.00129	0.0162	CcSEcCtD
Alprostadil—Vasodilation procedure—Thalidomide—leprosy	0.00129	0.0162	CcSEcCtD
Alprostadil—Accidental injury—Thalidomide—leprosy	0.00128	0.0161	CcSEcCtD
Alprostadil—Musculoskeletal stiffness—Thalidomide—leprosy	0.00126	0.0159	CcSEcCtD
Alprostadil—SLCO2A1—eye—leprosy	0.00125	0.0641	CbGeAlD
Alprostadil—PTGER1—nervous system—leprosy	0.00125	0.0638	CbGeAlD
Alprostadil—Hyperbilirubinaemia—Thalidomide—leprosy	0.00124	0.0156	CcSEcCtD
Alprostadil—Hypercholesterolaemia—Thalidomide—leprosy	0.0012	0.015	CcSEcCtD
Alprostadil—Sinusitis—Dapsone—leprosy	0.00116	0.0146	CcSEcCtD
Alprostadil—Hyperkalaemia—Thalidomide—leprosy	0.00111	0.014	CcSEcCtD
Alprostadil—Pharyngitis—Dapsone—leprosy	0.0011	0.0138	CcSEcCtD
Alprostadil—SLCO2A1—skin of body—leprosy	0.00109	0.0557	CbGeAlD
Alprostadil—Cramps of lower extremities—Thalidomide—leprosy	0.00104	0.0131	CcSEcCtD
Alprostadil—Sepsis—Thalidomide—leprosy	0.000982	0.0123	CcSEcCtD
Alprostadil—Erythema—Dapsone—leprosy	0.000966	0.0121	CcSEcCtD
Alprostadil—Diabetes mellitus—Thalidomide—leprosy	0.000944	0.0119	CcSEcCtD
Alprostadil—Cardiac failure congestive—Thalidomide—leprosy	0.000906	0.0114	CcSEcCtD
Alprostadil—Injury—Thalidomide—leprosy	0.000894	0.0112	CcSEcCtD
Alprostadil—Cough—Dapsone—leprosy	0.000843	0.0106	CcSEcCtD
Alprostadil—Hypoglycaemia—Thalidomide—leprosy	0.000842	0.0106	CcSEcCtD
Alprostadil—Lethargy—Thalidomide—leprosy	0.000838	0.0105	CcSEcCtD
Alprostadil—SLCO3A1—tendon—leprosy	0.000837	0.0428	CbGeAlD
Alprostadil—SLCO2A1—tendon—leprosy	0.000829	0.0424	CbGeAlD
Alprostadil—Pain in extremity—Thalidomide—leprosy	0.000821	0.0103	CcSEcCtD
Alprostadil—PTGIR—testis—leprosy	0.000786	0.0402	CbGeAlD
Alprostadil—Cardiac arrest—Thalidomide—leprosy	0.000781	0.00982	CcSEcCtD
Alprostadil—PTGIR—nervous system—leprosy	0.000771	0.0394	CbGeAlD
Alprostadil—Tachycardia—Dapsone—leprosy	0.00077	0.00968	CcSEcCtD
Alprostadil—Blood creatinine increased—Thalidomide—leprosy	0.00077	0.00967	CcSEcCtD
Alprostadil—ABCC5—tendon—leprosy	0.000758	0.0388	CbGeAlD
Alprostadil—Hypokalaemia—Thalidomide—leprosy	0.000748	0.0094	CcSEcCtD
Alprostadil—Influenza—Thalidomide—leprosy	0.00071	0.00892	CcSEcCtD
Alprostadil—SLCO3A1—testis—leprosy	0.000693	0.0355	CbGeAlD
Alprostadil—SLCO2A1—testis—leprosy	0.000687	0.0351	CbGeAlD
Alprostadil—Bronchitis—Thalidomide—leprosy	0.000683	0.00858	CcSEcCtD
Alprostadil—SLCO3A1—nervous system—leprosy	0.00068	0.0348	CbGeAlD
Alprostadil—SLCO2A1—nervous system—leprosy	0.000674	0.0345	CbGeAlD
Alprostadil—Upper respiratory tract infection—Thalidomide—leprosy	0.00066	0.00829	CcSEcCtD
Alprostadil—Pollakiuria—Thalidomide—leprosy	0.000656	0.00824	CcSEcCtD
Alprostadil—Hyperglycaemia—Thalidomide—leprosy	0.00064	0.00805	CcSEcCtD
Alprostadil—ABCC5—testis—leprosy	0.000628	0.0321	CbGeAlD
Alprostadil—Acute coronary syndrome—Thalidomide—leprosy	0.000624	0.00784	CcSEcCtD
Alprostadil—Abdominal pain—Dapsone—leprosy	0.000623	0.00784	CcSEcCtD
Alprostadil—Body temperature increased—Dapsone—leprosy	0.000623	0.00784	CcSEcCtD
Alprostadil—Renal failure—Thalidomide—leprosy	0.000622	0.00782	CcSEcCtD
Alprostadil—Myocardial infarction—Thalidomide—leprosy	0.000621	0.0078	CcSEcCtD
Alprostadil—Haematuria—Thalidomide—leprosy	0.000604	0.00759	CcSEcCtD
Alprostadil—Sinusitis—Thalidomide—leprosy	0.000594	0.00747	CcSEcCtD
Alprostadil—SLCO2B1—tendon—leprosy	0.000594	0.0304	CbGeAlD
Alprostadil—Bradycardia—Thalidomide—leprosy	0.000579	0.00727	CcSEcCtD
Alprostadil—Rhinitis—Thalidomide—leprosy	0.00057	0.00716	CcSEcCtD
Alprostadil—Hypoaesthesia—Thalidomide—leprosy	0.000565	0.00711	CcSEcCtD
Alprostadil—Pharyngitis—Thalidomide—leprosy	0.000564	0.00709	CcSEcCtD
Alprostadil—Urethral disorder—Thalidomide—leprosy	0.000557	0.007	CcSEcCtD
Alprostadil—Visual impairment—Thalidomide—leprosy	0.000548	0.00688	CcSEcCtD
Alprostadil—ABCC4—tendon—leprosy	0.000526	0.0269	CbGeAlD
Alprostadil—Headache—Dapsone—leprosy	0.000494	0.00621	CcSEcCtD
Alprostadil—SLCO2B1—testis—leprosy	0.000492	0.0251	CbGeAlD
Alprostadil—SLCO2B1—nervous system—leprosy	0.000482	0.0247	CbGeAlD
Alprostadil—Nervousness—Thalidomide—leprosy	0.00048	0.00604	CcSEcCtD
Alprostadil—Back pain—Thalidomide—leprosy	0.000479	0.00602	CcSEcCtD
Alprostadil—Muscle spasms—Thalidomide—leprosy	0.000476	0.00598	CcSEcCtD
Alprostadil—Nausea—Dapsone—leprosy	0.000468	0.00589	CcSEcCtD
Alprostadil—Anaemia—Thalidomide—leprosy	0.000457	0.00575	CcSEcCtD
Alprostadil—Syncope—Thalidomide—leprosy	0.000444	0.00558	CcSEcCtD
Alprostadil—ABCC4—testis—leprosy	0.000435	0.0223	CbGeAlD
Alprostadil—Loss of consciousness—Thalidomide—leprosy	0.000435	0.00547	CcSEcCtD
Alprostadil—Cough—Thalidomide—leprosy	0.000432	0.00543	CcSEcCtD
Alprostadil—Convulsion—Thalidomide—leprosy	0.000429	0.00539	CcSEcCtD
Alprostadil—ABCC4—nervous system—leprosy	0.000427	0.0219	CbGeAlD
Alprostadil—Hypertension—Thalidomide—leprosy	0.000427	0.00537	CcSEcCtD
Alprostadil—Discomfort—Thalidomide—leprosy	0.000416	0.00523	CcSEcCtD
Alprostadil—Dry mouth—Thalidomide—leprosy	0.000412	0.00518	CcSEcCtD
Alprostadil—Oedema—Thalidomide—leprosy	0.000404	0.00508	CcSEcCtD
Alprostadil—Infection—Thalidomide—leprosy	0.000401	0.00504	CcSEcCtD
Alprostadil—Shock—Thalidomide—leprosy	0.000397	0.00499	CcSEcCtD
Alprostadil—Thrombocytopenia—Thalidomide—leprosy	0.000395	0.00497	CcSEcCtD
Alprostadil—Tachycardia—Thalidomide—leprosy	0.000394	0.00495	CcSEcCtD
Alprostadil—Skin disorder—Thalidomide—leprosy	0.000392	0.00493	CcSEcCtD
Alprostadil—Hyperhidrosis—Thalidomide—leprosy	0.00039	0.00491	CcSEcCtD
Alprostadil—Hypotension—Thalidomide—leprosy	0.000377	0.00474	CcSEcCtD
Alprostadil—Dyspepsia—Thalidomide—leprosy	0.000355	0.00447	CcSEcCtD
Alprostadil—Pain—Thalidomide—leprosy	0.000345	0.00434	CcSEcCtD
Alprostadil—Feeling abnormal—Thalidomide—leprosy	0.000333	0.00418	CcSEcCtD
Alprostadil—Abdominal pain—Thalidomide—leprosy	0.000319	0.00401	CcSEcCtD
Alprostadil—Body temperature increased—Thalidomide—leprosy	0.000319	0.00401	CcSEcCtD
Alprostadil—Asthenia—Thalidomide—leprosy	0.00029	0.00364	CcSEcCtD
Alprostadil—Pruritus—Thalidomide—leprosy	0.000286	0.00359	CcSEcCtD
Alprostadil—Diarrhoea—Thalidomide—leprosy	0.000276	0.00347	CcSEcCtD
Alprostadil—Dizziness—Thalidomide—leprosy	0.000267	0.00336	CcSEcCtD
Alprostadil—Rash—Thalidomide—leprosy	0.000255	0.0032	CcSEcCtD
Alprostadil—Dermatitis—Thalidomide—leprosy	0.000254	0.0032	CcSEcCtD
Alprostadil—Headache—Thalidomide—leprosy	0.000253	0.00318	CcSEcCtD
Alprostadil—Nausea—Thalidomide—leprosy	0.00024	0.00301	CcSEcCtD
